Ruth Coll

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 412 citations · Full text

Urology, Oncology, Genitourinary Cancer +2

Final results of a phase I–II trial using ex vivo expanded autologous Mesenchymal Stromal Cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration

Robert Soler, Lluís Orozco, Ana Munar et al. · The Knee · 2016 · 172 citations

Tissue Engineering, Regenerative Medicine, Engineering +14

Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study

Sergiu Albu, Hatice Kumru, Ruth Coll et al. · Cytotherapy · 2020 · 104 citations

Regenerative Medicine, Expanded Wharton, Spinal Cord Injury +10

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft

Cristina Prat‐Vidal, Luciano Rodríguez-Gómez, Miriam Aylagas et al. · EBioMedicine · 2020 · 47 citations · Full text

Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery

Ana García de Frutos, Pilar González-Tartière, Ruth Coll et al. · The Spine Journal · 2020 · 40 citations

Regenerative Medicine, Tissue Engineering, Randomized Clinical Trial +11